GOLDMAN SACHS GROUP INC - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 27 filers reported holding BIOCEPT INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$3,707
-95.1%
10,903
-48.3%
0.00%
Q4 2021$76,0000.0%21,079
+10.7%
0.00%
Q3 2021$76,00019,0500.00%
Other shareholders
BIOCEPT INC shareholders Q1 2023
NameSharesValueWeighting ↓
OCCUDO QUANTITATIVE STRATEGIES LP 31,132$138,0000.04%
SABBY MANAGEMENT, LLC 31,578$140,0000.03%
DRIEHAUS CAPITAL MANAGEMENT LLC 111,111$493,0000.01%
Virtu Financial LLC 14,647$65,0000.01%
HUSSMAN STRATEGIC ADVISORS, INC. 3,500$16,0000.00%
Larson Financial Group LLC 1,000$4,0000.00%
VANGUARD GROUP INC 667,242$2,963,0000.00%
Advisory Services Network, LLC 1$00.00%
Man Group plc 16,600$74,0000.00%
OSAIC HOLDINGS, INC. 7,000$31,0000.00%
View complete list of BIOCEPT INC shareholders